Our plain-English summary of Cytological Diagnosis of Malignant Mesothelioma: A Case Series, by S. Dahiya, M. Singh, S. Jain, et al (Journal of Cytology, 2022).
You don't need the product names or old records. No fee unless we recover compensation for your family.
The study
- Authors: S. Dahiya, M. Singh, S. Jain, B. Khuraijam, N. Suroya, S. Mandal
- Journal: Journal of Cytology
- Published: 2022;39(3):105-109
- Cited by: 4 articles, as counted by NIH iCite
- Read it: PubMed · Publisher · Free full text
Abstract
Background: Mesotheliomas are neoplasms of the serosal lining of the body cavities. Diagnosis requires a multimodal approach of clinical findings, cytology, and histopathology with immunohistochemistry (IHC). The published sensitivity of cytology for diagnosing mesothelioma ranges from 30% to 75%.
Aim And Objectives: This study aimed to calculate the incidence of malignant mesothelioma (MM) at our institute and to study the cytological features of MM.
Materials And Methods: A retrospective study of pleural, peritoneal, and pericardial fluids submitted at our institute was done. The duration of the study was 8 years (2011-2019). Apart from examining Giemsa smears, a panel of immunocytochemical (ICC) and cell block immunohistochemical (IHC) markers was applied to achieve the diagnosis. These included calretinin, mesothelin, CK5/6, Hector Battifora mesothelial cell antibody (HBME), WT1, MOC31, CK7 and CK20. Histopathological correlation was done wherever possible.
Result: In the present study, we compiled four cases of MM over 8 years diagnosed on serous effusion cytology and confirmed by immunocytochemistry (ICC)/cell block immunohistochemistry (IHC)/biopsy. This indicates a rare incidence of MM. The Cytological features of MM were studied.
Conclusion: The diagnosis of MM is difficult, especially cytologically. It was found to be a rare entity in the malignant cases diagnosed on effusion cytology.
Copyright: © 2022 Journal of Cytology.
In plain English
In this case series, pathologists in Delhi, India, reviewed 3,372 pleural, peritoneal and pericardial fluid samples submitted between January 2011 and October 2019. Twelve cases were suspected to be malignant mesothelioma on first screening. After further marker staining and, where possible, tissue examination, 4 of the 12 were confirmed as malignant mesothelioma. Of the other eight, seven were reactive (non-cancerous) mesothelial proliferations and one was adenocarcinoma. Three mesotheliomas were pleural and one peritoneal. The patients were aged 40 to 55, three men and one woman. One pleural case looked like adenocarcinoma on cytology and was identified as mesothelioma only after marker staining. The authors reported that cytology had a sensitivity of 75%, a specificity of 96%, and positive and negative predictive values of 27.2% and 99.4%. They calculated an incidence of 0.12%, which matches four cases among the 3,372 fluid samples at this institute; it is not a population rate. They stated that none of their cases were linked to asbestos exposure. The authors concluded that mesothelioma is rare in India and that fluid cytology can be a good first method of diagnosis.
We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.
What the study did and found
- Design: Case series drawn from a retro-prospective review of fluid samples at one institute
- Who was studied: 3,372 fluid samples (2,468 peritoneal, 732 pleural, 172 pericardial) submitted January 2011 to October 2019 to the Department of Pathology, Maulana Azad Medical College, Delhi, India. Only cases suspected to be mesothelioma were worked up further.
- Exposure: Asbestos exposure was not studied. The authors stated that none of their cases were linked to asbestos exposure. No fiber types are named.
- Main results:
- 12 cases were suspected to be malignant mesothelioma on primary cytospin screening. 4 of these 12 were confirmed as malignant mesothelioma.
- Of the remaining 8 suspected cases, 7 were reactive mesothelial proliferations and 1 was adenocarcinoma.
- Case 4 (a 55-year-old man with pleural effusion) looked like adenocarcinoma on primary screening but was found to be mesothelioma after marker staining.
- Cytological examination: sensitivity 75%, specificity 96%, positive predictive value 27.2%, negative predictive value 99.4%.
- With four cases diagnosed, the overall incidence was calculated as 0.12%. This matches 4 cases among the 3,372 fluid samples submitted to this institute. It is not a population incidence.
- Three cases were pleural: total incidence 0.4%, and 3.3% of malignant pleural cases.
- One case was peritoneal, giving 0.9% of malignant peritoneal cases (total incidence 0.04%).
- The patients with mesothelioma were aged 40 to 55 years, with a male to female ratio of 3 to 1.
- Cases 1, 2 and 3 showed atypical mesothelial cells in three-dimensional clusters and balls with scalloped edges.
- The authors' conclusion: The authors concluded that malignant mesothelioma is rare in India. They concluded that, although a multimodal approach is needed, cytology can be a good primary and effective method for a pathological diagnosis of mesothelioma.
Topics
Medical terms in this study, explained in our Lexicon: Mesothelioma, Neoplasm, Cytology, Histopathology, Immunohistochemistry, Pericardial, Cell Block, Calretinin.
Related studies
- Validation of a Gene Expression Approach for the Cytological Diagnosis of Epithelioid and Biphasic Pleural Mesothelioma on a Consecutive Series — R. Bruno, A.M. Poma, et al. (2023)
- Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry — X.Y. Su, G.D. Li, et al. (2011)
- Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions — S. Lonardi, C. Manera, et al. (2011)
- Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma — S. Muruganandan, H. Alfonso, et al. (2017)
- Improving the cytological diagnosis of high-grade serous carcinoma in ascites with a panel of complementary biomarkers in cell blocks — X. Zhang, L. Chen, et al. (2018)
- Preoperative cytological diagnosis of malignant mesothelioma of tunica vaginalis — A. Bandyopadhyay, S. Bhattacharya, et al. (2015)
Browse return to medical research.
How to cite it
Cite the study
S. Dahiya, M. Singh, S. Jain, B. Khuraijam, N. Suroya, S. Mandal. Cytological Diagnosis of Malignant Mesothelioma: A Case Series. Journal of Cytology 2022;39(3):105-109. doi:10.4103/joc.joc_145_21. PMID: 36277806.
Cite our summary
“Cytological Diagnosis of Malignant Mesothelioma: A Case Series.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/cytological-diagnosis-of-malignant-mesothelioma-a-case-series.
ACL Doc numbers and their short links never change. See how to cite the Library.
Talk with an asbestos lawyer
Start with what you remember, and we'll take it from there.
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.